HK Stock MarketDetailed Quotes

CHINAHEALTHWISE (00348)

Watchlist
  • 0.066
  • -0.013-16.46%
Market Closed May 21 16:08 CST
50.85MMarket Cap-22.00P/E (TTM)

CHINAHEALTHWISE (00348) Cash Flow

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q6)Jun 30, 2025
(FY)Dec 31, 2024
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
Cash flow from operating activities
Earning before tax
91.78%-3.29M
----
69.69%-40.03M
----
-134.14%-132.06M
----
43.92%-56.4M
----
-274.06%-100.58M
----
Profit adjustment
Interest expense - adjustment
66.62%13.83M
----
-7.72%8.3M
----
23.24%8.99M
----
13.84%7.3M
----
-67.86%6.41M
----
Impairment and provisions:
-176.57%-2.41M
----
-97.08%3.15M
----
324.27%107.79M
----
-76.00%25.41M
----
104.65%105.85M
----
-Impairment of property, plant and equipment (reversal)
----
----
----
----
----
----
----
----
30.12%216K
----
-Other impairments and provisions
-176.57%-2.41M
----
-97.08%3.15M
----
324.27%107.79M
----
-75.95%25.41M
----
105.03%105.63M
----
Revaluation surplus:
-685.29%-24.51M
----
-59.52%4.19M
----
-32.50%10.34M
----
0.16%15.33M
----
182.86%15.3M
----
-Derivative financial instruments fair value (increase)
--100K
----
----
----
----
----
----
----
----
----
-Other fair value changes
-687.68%-24.61M
----
-59.52%4.19M
----
-32.50%10.34M
----
0.16%15.33M
----
182.86%15.3M
----
Depreciation and amortization:
-10.66%6.41M
----
27.69%7.17M
----
69.95%5.62M
----
-21.30%3.3M
----
-60.35%4.2M
----
Special items
-99.97%2K
----
315,000.00%6.3M
----
100.08%2K
----
-1,622.37%-2.62M
----
82.12%-152K
----
Operating profit before the change of operating capital
8.72%-9.97M
----
-1,694.74%-10.92M
----
108.91%685K
----
-124.78%-7.69M
----
126.63%31.02M
----
Change of operating capital
Inventory (increase) decrease
54.44%9.66M
----
793.24%6.25M
----
-116.13%-902K
----
143.86%5.59M
----
-2,517.86%-12.75M
----
Accounts receivable (increase)decrease
-55.78%2.16M
----
391.15%4.88M
----
134.54%994K
----
-266.74%-2.88M
----
102.16%1.73M
----
Accounts payable increase (decrease)
309.99%7.67M
----
-47.62%-3.65M
----
-124.18%-2.47M
----
39.41%10.23M
----
-88.35%7.34M
----
Financial assets at fair value (increase)decrease
-32.91%265K
----
-93.97%395K
----
149.12%6.55M
----
-140.29%-13.33M
----
33.65%33.1M
----
Special items for working capital changes
-14.70%5.27M
----
-34.89%6.18M
----
146.82%9.49M
----
-12.17%-20.26M
----
-127.51%-18.06M
----
Cash  from business operations
380.61%15.05M
----
-78.16%3.13M
----
150.60%14.34M
----
-166.89%-28.34M
----
219.37%42.37M
----
Other taxs
----
----
----
----
--153K
----
----
----
77.80%-285K
----
Special items of business
----
86.42%-347K
----
-940.79%-2.56M
----
101.16%304K
----
-289.49%-26.2M
----
165.00%13.83M
Net cash from operations
380.61%15.05M
86.42%-347K
-78.39%3.13M
-940.79%-2.56M
151.14%14.49M
101.16%304K
-167.34%-28.34M
-289.49%-26.2M
250.98%42.08M
165.00%13.83M
Cash flow from investment activities
Purchase of fixed assets
63.81%-93K
----
-34.55%-257K
----
69.73%-191K
----
-75.28%-631K
----
92.03%-360K
----
Cash on investment
2,299.60%5.93M
----
--247K
----
----
----
----
----
----
----
Other items in the investment business
----
40.43%-84K
----
-2,250.00%-141K
----
82.86%-6K
----
89.06%-35K
----
-101.96%-320K
Net cash from investment operations
58,440.00%5.83M
40.43%-84K
94.76%-10K
-2,250.00%-141K
69.73%-191K
82.86%-6K
-75.28%-631K
89.06%-35K
-124.06%-360K
-101.96%-320K
Net cash before financing
569.08%20.88M
84.02%-431K
-78.18%3.12M
-1,005.03%-2.7M
149.36%14.3M
101.14%298K
-169.43%-28.97M
-294.23%-26.24M
209.38%41.72M
371.27%13.51M
Cash flow from financing activities
New borrowing
-65.58%3.26M
----
847.20%9.47M
----
-94.80%1M
----
--19.23M
----
----
----
Refund
-5.37%-5.92M
----
-58.72%-5.62M
----
---3.54M
----
----
----
38.66%-21.16M
----
Interest paid - financing
-159.63%-11.74M
----
42.46%-4.52M
----
-12.77%-7.86M
----
6.61%-6.97M
----
11.94%-7.46M
----
Other items of the financing business
----
-3.88%-4.91M
----
45.14%-4.72M
----
-156.83%-8.61M
----
173.47%15.15M
----
-18.39%-20.62M
Net cash from financing operations
-172.71%-21.39M
-3.88%-4.91M
53.96%-7.84M
45.14%-4.72M
-386.14%-17.04M
-156.83%-8.61M
116.37%5.95M
173.47%15.15M
-41.22%-36.36M
-18.39%-20.62M
Effect of rate
-300.00%-6K
-66.67%1K
-99.02%3K
-99.01%3K
317.73%307K
288.20%303K
22.10%-141K
22.60%-161K
-1,005.00%-181K
-1,980.00%-208K
Net Cash
89.22%-509K
28.08%-5.34M
-72.62%-4.72M
10.72%-7.42M
88.11%-2.74M
25.09%-8.31M
-529.48%-23.02M
-56.09%-11.09M
143.70%5.36M
68.26%-7.11M
Begining period cash
-32.73%9.7M
-32.73%9.7M
-14.42%14.42M
-14.42%14.42M
-57.88%16.85M
-57.88%16.85M
14.87%40.01M
14.87%40.01M
-26.01%34.83M
-26.01%34.83M
Cash at the end
-5.31%9.19M
-37.67%4.37M
-32.73%9.7M
-20.78%7.01M
-14.42%14.42M
-69.24%8.84M
-57.88%16.85M
4.50%28.75M
14.87%40.01M
11.54%27.51M
Cash balance analysis
Currency Unit
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
--
--
--
--
--
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
(FY)Dec 31, 2025(Q6)Jun 30, 2025(FY)Dec 31, 2024(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021
Cash flow from operating activities
Earning before tax 91.78%-3.29M----69.69%-40.03M-----134.14%-132.06M----43.92%-56.4M-----274.06%-100.58M----
Profit adjustment
Interest expense - adjustment 66.62%13.83M-----7.72%8.3M----23.24%8.99M----13.84%7.3M-----67.86%6.41M----
Impairment and provisions: -176.57%-2.41M-----97.08%3.15M----324.27%107.79M-----76.00%25.41M----104.65%105.85M----
-Impairment of property, plant and equipment (reversal) --------------------------------30.12%216K----
-Other impairments and provisions -176.57%-2.41M-----97.08%3.15M----324.27%107.79M-----75.95%25.41M----105.03%105.63M----
Revaluation surplus: -685.29%-24.51M-----59.52%4.19M-----32.50%10.34M----0.16%15.33M----182.86%15.3M----
-Derivative financial instruments fair value (increase) --100K------------------------------------
-Other fair value changes -687.68%-24.61M-----59.52%4.19M-----32.50%10.34M----0.16%15.33M----182.86%15.3M----
Depreciation and amortization: -10.66%6.41M----27.69%7.17M----69.95%5.62M-----21.30%3.3M-----60.35%4.2M----
Special items -99.97%2K----315,000.00%6.3M----100.08%2K-----1,622.37%-2.62M----82.12%-152K----
Operating profit before the change of operating capital 8.72%-9.97M-----1,694.74%-10.92M----108.91%685K-----124.78%-7.69M----126.63%31.02M----
Change of operating capital
Inventory (increase) decrease 54.44%9.66M----793.24%6.25M-----116.13%-902K----143.86%5.59M-----2,517.86%-12.75M----
Accounts receivable (increase)decrease -55.78%2.16M----391.15%4.88M----134.54%994K-----266.74%-2.88M----102.16%1.73M----
Accounts payable increase (decrease) 309.99%7.67M-----47.62%-3.65M-----124.18%-2.47M----39.41%10.23M-----88.35%7.34M----
Financial assets at fair value (increase)decrease -32.91%265K-----93.97%395K----149.12%6.55M-----140.29%-13.33M----33.65%33.1M----
Special items for working capital changes -14.70%5.27M-----34.89%6.18M----146.82%9.49M-----12.17%-20.26M-----127.51%-18.06M----
Cash  from business operations 380.61%15.05M-----78.16%3.13M----150.60%14.34M-----166.89%-28.34M----219.37%42.37M----
Other taxs ------------------153K------------77.80%-285K----
Special items of business ----86.42%-347K-----940.79%-2.56M----101.16%304K-----289.49%-26.2M----165.00%13.83M
Net cash from operations 380.61%15.05M86.42%-347K-78.39%3.13M-940.79%-2.56M151.14%14.49M101.16%304K-167.34%-28.34M-289.49%-26.2M250.98%42.08M165.00%13.83M
Cash flow from investment activities
Purchase of fixed assets 63.81%-93K-----34.55%-257K----69.73%-191K-----75.28%-631K----92.03%-360K----
Cash on investment 2,299.60%5.93M------247K----------------------------
Other items in the investment business ----40.43%-84K-----2,250.00%-141K----82.86%-6K----89.06%-35K-----101.96%-320K
Net cash from investment operations 58,440.00%5.83M40.43%-84K94.76%-10K-2,250.00%-141K69.73%-191K82.86%-6K-75.28%-631K89.06%-35K-124.06%-360K-101.96%-320K
Net cash before financing 569.08%20.88M84.02%-431K-78.18%3.12M-1,005.03%-2.7M149.36%14.3M101.14%298K-169.43%-28.97M-294.23%-26.24M209.38%41.72M371.27%13.51M
Cash flow from financing activities
New borrowing -65.58%3.26M----847.20%9.47M-----94.80%1M------19.23M------------
Refund -5.37%-5.92M-----58.72%-5.62M-------3.54M------------38.66%-21.16M----
Interest paid - financing -159.63%-11.74M----42.46%-4.52M-----12.77%-7.86M----6.61%-6.97M----11.94%-7.46M----
Other items of the financing business -----3.88%-4.91M----45.14%-4.72M-----156.83%-8.61M----173.47%15.15M-----18.39%-20.62M
Net cash from financing operations -172.71%-21.39M-3.88%-4.91M53.96%-7.84M45.14%-4.72M-386.14%-17.04M-156.83%-8.61M116.37%5.95M173.47%15.15M-41.22%-36.36M-18.39%-20.62M
Effect of rate -300.00%-6K-66.67%1K-99.02%3K-99.01%3K317.73%307K288.20%303K22.10%-141K22.60%-161K-1,005.00%-181K-1,980.00%-208K
Net Cash 89.22%-509K28.08%-5.34M-72.62%-4.72M10.72%-7.42M88.11%-2.74M25.09%-8.31M-529.48%-23.02M-56.09%-11.09M143.70%5.36M68.26%-7.11M
Begining period cash -32.73%9.7M-32.73%9.7M-14.42%14.42M-14.42%14.42M-57.88%16.85M-57.88%16.85M14.87%40.01M14.87%40.01M-26.01%34.83M-26.01%34.83M
Cash at the end -5.31%9.19M-37.67%4.37M-32.73%9.7M-20.78%7.01M-14.42%14.42M-69.24%8.84M-57.88%16.85M4.50%28.75M14.87%40.01M11.54%27.51M
Cash balance analysis
Currency Unit HKDHKDHKDHKDHKDHKDHKDHKDHKDHKD
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions ------------Unqualified Opinion--Unqualified Opinion--
Auditor National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More